Cocchetto D M, Sykes R S, Spector S
Glaxo Inc., Research Triangle Park, North Carolina.
J Asthma. 1991;28(1):49-53. doi: 10.3109/02770909109073370.
Various formulations of beta-agonists and other bronchodilators have been associated with unexpected bronchoconstriction in certain individuals. Even though the number of affected individuals represents a relatively small percentage and the etiologies may differ among patients, it is important for the public to be aware of the potential for paradoxical bronchospasm and for the physician to investigate each case accordingly.
在某些个体中,β受体激动剂和其他支气管扩张剂的各种制剂已与意外的支气管收缩相关联。尽管受影响个体的数量占比相对较小,且患者之间的病因可能不同,但让公众了解矛盾性支气管痉挛的可能性以及让医生对每个病例进行相应调查很重要。